A recent FiercePharma article discussed the recall of Pfizer’s menopause drug, Duavee. The company voluntarily recalled two batches of the drug, which is marketed as Duavive abroad, over concerns of faulty packaging that might have reduced efficacy. A flaw in the drug’s foil laminate pouch allows oxygen to pass through, lowering the dissolution rate of the active pharmaceutical ingredient, bazedoxifene acetate.
Quick Hits: Faulty Packaging Prompts Pfizer Recalls in UK
The drug’s packaging featured a flaw that lowered the dissolution rate of the API.
Jun 26, 2020